Lucid Diagnostics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $1,474 | $1,256 | $1,504 | $1,211 |
Gross Profit | 29 | -591 | -356 | -486 |
EBITDA | -11,459 | -13,681 | -16,051 | -10,175 |
EBIT | -11,683 | -13,903 | -16,260 | -10,395 |
Net Income | -11,687 | -13,909 | -16,266 | -10,397 |
Net Change In Cash | 1,474 | 1,256 | 1,504 | 1,211 |
Free Cash Flow | -11,318 | -12,316 | -12,629 | -10,921 |
Cash | 33,404 | 27,876 | 34,705,000 | 47,332 |
Basic Shares | 183,124 | 101,947 | 101,947 | 108,176 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,706 | $4,346 | $2,428 | $377 |
Gross Profit | -2,836 | -3,920 | -6,050 | -3,237 |
EBITDA | -57,116 | -44,336 | -49,751 | -54,227 |
EBIT | -57,988 | -45,503 | -52,250 | -56,163 |
Net Income | -58,010 | -45,529 | -52,666 | -56,171 |
Net Change In Cash | 4,706 | 4,346 | 2,428 | 377 |
Cost of Revenue | -31,182 | |||
Free Cash Flow | -46,485 | -44,786 | -33,038 | -30,593 |
Cash | 34,705 | 22,358 | 18,896 | 22,474 |
Basic Shares | 101,947 | 50,516 | 41,756 | 36,172 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.08 |
2026-03-31 | -$0.07 |
2025-12-31 | -$0.10 |
2025-09-30 | -$0.10 |